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Abstract. 
 
Cumulative evidence indicates that osteo-
blasts and adipocytes share a common mesenchymal 
precursor and that bone morphogenetic proteins 
(BMPs) can induce both osteoblast and adipocyte dif-
ferentiation of this precursor. In the present study, we 
investigated the roles of BMP receptors in differentia-
tion along these separate lineages using a well-charac-
terized clonal cell line, 2T3, derived from the mouse 
calvariae. BMP-2 induced 2T3 cells to differentiate into 
mature osteoblasts or adipocytes depending upon cul-
ture conditions. To test the specific roles of the type IA 
and IB BMP receptor components, truncated and con-
stitutively active type IA and IB BMP receptor cDNAs 
were stably expressed in these cells. Overexpression of 
truncated type IB BMP receptor (trBMPR-IB) in 2T3 
cells completely blocked BMP-2–induced osteoblast 
differentiation and mineralized bone matrix formation. 
Expression of trBMPR-IB also blocked mRNA expres-
sion of the osteoblast specific transcription factor, Osf2/
Cbfa1, and the osteoblast differentiation-related genes, 
alkaline phosphatase (ALP) and osteocalcin (OC). 
BMP-2–induced ALP activity could be rescued by 
transfection of wild-type (wt) BMPR-IB into 2T3 
clones containing trBMPR-IB. Expression of a consti-
tutively active BMPR-IB (caBMPR-IB) induced for-
mation of mineralized bone matrix by 2T3 cells without 
addition of BMP-2. In contrast, overexpression of trB-
MPR-IA blocked adipocyte differentiation and expres-
sion of caBMPR-IA induced adipocyte formation in 
2T3 cells. Expression of the adipocyte differentiation-
related genes, adipsin and PPAR
 
g
 
, correlated with the 
distinct phenotypic changes found after overexpression 
of the appropriate mutant receptors. These results 
demonstrate that type IB and IA BMP receptors trans-
mit different signals to bone-derived mesenchymal pro-
genitors and play critical roles in both the specification 
and differentiation of osteoblasts and adipocytes.
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P
 
luripotent 
 
mesenchymal cells are able to differen-
tiate into several distinct cell types, including
osteoblasts and adipocytes (Taylor and Jones, 1979;
Friedenstein et al., 1987), but the regulatory mechanisms
responsible remain undefined. Bone morphogenic pro-
teins (BMPs)
 
1
 
 were originally identified as peptides that
induce bone and cartilage formation in ectopic extraskele-
tal sites in vivo (Wang et al., 1988, 1990; Wozney et al.,
1988). Extensive studies have demonstrated that BMPs
play important roles in bone formation and bone cell dif-
ferentiation (Wozney et al., 1988; Harris et al., 1994,
1995; Chen et al., 1997), but the activities of the BMPs are
not restricted to bone and cartilage formation. BMPs ap-
pear to be involved in most morphogenetic processes dur-
ing development (Winnier et al., 1995; Hogan, 1996).
BMP-2 and BMP-4 induce ventral mesoderm formation
during embryogenesis and differentiation of cells with me-
sodermal origins (Winnier et al., 1995). Addition of recom-
binant BMP-2 and BMP-7 or transfection of BMP-2 and
BMP-4 cDNA in a pluripotent mouse fibroblast cell line,
C3H10T1/2, induces the cells to differentiate into three cell
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1.
 
Abbreviations used in this paper
 
: 
 
a
 
MEM, 
 
a 
 
minimal essential medium;
aa, amino acids; ALP, alkaline phosphatase; BMP, bone morphogenic
protein; caBMPR-IB, constitutively active type IB BMP receptor; FRC,
fetal rat calvarial; HA, hemagglutinin; IBMX, 3-isobutyl-1-methyl xan-
thine; OC, osteocalcin; RT, reverse transcription; trBMPR-IB, truncated
type IB BMP receptor; wt, wild-type.
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types: osteoblasts, chondroblasts, and adipocytes (Ahrens
et al., 1993; Wang et al., 1993; Asahina et al., 1996). The re-
ceptor mediation for these effects of BMPs is not known.
Recently, several BMP (IA, IB, and II) and activin (I, II,
and IIB) receptors have been cloned and characterized
(Koenig et al., 1994; ten Dijke et al., 1994; Yamaji et al.,
1994; Kawabata et al., 1995; Liu et al., 1995; Nohno et al.,
1995; Rosenzweig et al., 1995; Ruberte et al., 1995; Ya-
mashita et al., 1995). These receptors bind BMP ligands
and transduce their signals. BMP and activin receptors be-
long to the TGF
 
b
 
 receptor family of serine/threonine ki-
nases. Although both type I and type II BMP receptors
bind BMP ligands, heteromers of type I and type II recep-
tors are required for a signal to be transduced (Nohno et
al., 1995; Ruberte et al., 1995). BMP-2 and BMP-4 bind
weakly to both type IA and IB receptors (ten Dijke et al.,
1994), but coexpression of type II BMP receptor with IA
or IB BMP receptor increases binding affinity and dramat-
ically enhances biological activity (Massagué, 1996). Type
I BMP receptors with mutations in the glycine/serine jux-
tatransmembrane domain have been defined. They have
the capacity to activate cells constitutively in the absence
of a BMP ligand (Hoodless et al., 1996). 
Previous studies have demonstrated that injection of
truncated type IA or type II BMP receptor mRNA into
 
Xenopus
 
 embryos blocks ventral mesoderm formation
(Graff et al., 1994; Maeno et al., 1994; Suzuki et al., 1994;
Ishikawa et al., 1995). Studies on viral mediated transfec-
tion of kinase defective and constitutively active BMPR-IA
and BMPR-IB in chicken embryos demonstrated that
these two receptors regulate distinct processes during
chick limb development. BMPR-IB is required for the ini-
tial steps of chondrogenesis and mediates programmed
cell death and BMPR-IA regulates the rate of chondro-
cyte differentiation (Zou and Niswander, 1995; Zou et al.,
1997). In chicken embryos, chondrogenesis of limb mesen-
chymal cells and bone formation of the distal limb bud are
markedly inhibited by dominant-negative type IB and
type II BMP receptors, but not by dominant-negative
BMPR-IA (Kawakami et al., 1996). The constitutively ac-
tive BMPR-IB increases distal cartilage fusion and dis-
rupts joint formation whereas the constitutively active
BMPR-IA delays chondrocyte differentiation (Zou et al.,
1997).   
In situ hybridization and immunohistochemistry studies
for expression of the two type I BMP receptors also sup-
port distinct roles of type IA and IB BMP receptors during
embryonic development. For example, high levels of
BMPR-IA are expressed in the rapidly growing loose mes-
enchymal cells surrounding the precartilaginous condensa-
tions (Yamaji et al., 1994; Dewulf et al., 1995) and BMPR-IA
is also selectively expressed in the prehypertrophic zone in
chick limbs (Zou et al., 1997). BMPR-IB is expressed in
the early differentiating cartilage condensations (Yamaji
et al., 1994; Dewulf et al., 1995). In 15-d-old mouse em-
bryos, expression of BMPR-IB, but not of BMPR-IA, was
observed in the cells of the perichondrium of developing
cartilage. At 17.5 and 19.5 d, respectively, expression of
both receptors was observed in chondrocytes and in osteo-
blasts. Thus, tissue-specific spatial and temporal expres-
sion of different types of BMPs and BMP receptors, as
well as inhibitors, such as chordin and noggin, may deter-
mine a specific function and threshold level of BMP action
(Holley et al., 1996; Piccolo et al., 1996; Zimmerman et al.,
1996; Graff, 1997; Tonegawa et al., 1997).
In the present study, we investigated the roles of type IA
and IB BMP receptors during osteoblast and adipocyte dif-
ferentiation using 2T3 cells. 2T3 cells were derived from the
calvaria of a transgenic mouse expressing T antigen driven
by the BMP-2 promoter and are primarily specified to dif-
ferentiate into mature osteoblasts (Ghosh-Choudhury et
al., 1996). Overexpression of the truncated and constitu-
tively active type IA and IB BMP receptors respecified
2T3 cells to differentiate into completely different pheno-
types. Our results suggest that type IA and IB BMP recep-
tors mediate different signals responsible for alternate
paths of differentiation and suggest that the temporal ac-
quisition or loss of a selective BMP receptor in unspecified
precursor cells may be a key step for the commitment and
specification of osteoblasts and adipocytes during differ-
entiation processes. 
 
Materials and Methods
 
Cell Culture
 
The 2T3 cell line was isolated and cloned from a transgenic mouse con-
taining BMP-2 promoter driving the SV-40 T antigen transgene and has
been characterized previously (Ghosh-Choudhury et al., 1996). These
cells are BMP-2 responsive and undergo bone matrix formation in vitro.
2T3 cells were plated into T-150 flasks (Costar Corp., Cambridge, MA) at
density of 2 
 
3 
 
10
 
6
 
 cells per flask for RNA extraction or plated on 24-well
plates (Costar Corp.) at density of 2 
 
3 
 
10
 
4
 
 cells per well for bone matrix
formation and adipocyte formation assays. For the mineralized bone ma-
trix formation assay, the cells were cultured with 
 
a
 
 minimal essential me-
dium (
 
a
 
MEM) supplemented with 10% FCS. When the cells reached con-
fluency (day 0), the medium was changed to 
 
a
 
MEM containing 5% FCS,
100 
 
m
 
g/ml ascorbic acid, and 5 mM 
 
b
 
-glycerol phosphate, with or without
recombinant BMP-2. The medium was changed every other day and fresh
reagents were added. To assay adipocyte formation, the cells were cul-
tured with 
 
a
 
MEM supplemented with 5% rabbit serum, 0.5 mM of
3-isobutyl-1-methyl xanthine (IBMX), and 60 mM of indomethacin. Ac-
cumulation of lipid droplets in the cytoplasm was determined by Oil red O
staining (Novikoff et al., 1980).
 
Northern Analysis 
 
Total RNA was isolated from 2T3 cells using RNAzol B method (Tel-test
Inc., Houston, TX). Enrichment of polyadenylated RNA was obtained us-
ing Stratagene oligo (dT) cellulose columns (Stratagene, San Diego, CA).
5 
 
m
 
g of poly (A
 
+
 
) RNA was denatured in 2.2 M of formaldehyde and 50%
formamide and then run on a 1% agarose gel containing 2.2 M of formal-
dehyde. The gel was transferred to a Nytran filter (Schleicher & Schuell,
Keene, NH) by capillary blotting with 20
 
3 
 
SSC (1
 
3 
 
SSC 
 
5 
 
150 mM NaCl,
15 mM Na citrate, pH 7.0). The RNA was then cross-linked to the filter by
UV irradiation (Stratalink; Stratagene). Prehybridization was carried out
at 42
 
8
 
C in 5
 
3 
 
SSC containing 50% formamide and 150 mg/ml of dena-
tured salmon sperm DNA. After a 1–2-h prehybridization, the DNA
probes were added to the hybridization solution at a concentration of 5 
 
3
 
10
 
5
 
 cpm/ml. Hybridization was carried out for 15 h at 42
 
8
 
C. The filters
were then washed twice with 2
 
3 
 
SSC and 0.1% SDS, once with 0.5% SSC
and 0.1% SDS, and once with 0.1
 
3 
 
SSC and 0.1% SDS at 56
 
8
 
C for 15 min
each. The filters were dried at room temperature, exposed at 
 
2
 
70
 
8
 
C over-
night and then quantitated in cpm using an AMBIS image acquisition and
analysis system (AMBIS, San Diego, CA). The type IA, IB, and type II
BMP receptor probes are rat and human DNA fragments encoding the
extracellular domain of BMP receptors (0.5 kb). The alkaline phosphatase
(ALP) and osteocalcin (OC) probes are rat cDNA fragments (1.3 and 0.5
kb). The Osf2/Cbfa1, adipsin, and PPAR
 
g
 
 cDNA probes are mouse
cDNA fragments of 0.3, 0.5, and 1.8 kb, respectively. 
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Construction of Expression Plasmids
 
Truncated forms of type IA and IB BMP receptors were generated by the
PCR method using rat BMPR-IA (CFK-23a) and BMPR-IB (CFK-43a)
cDNAs as templates. The human homologue of CFK-23a is ALK-3
(EMBL/GenBank/DDBJ accession number Z22535) and mouse homo-
logue of CFK43a is ALK-6 (accession number Z23143). The deletion mu-
tants of BMPR-IA and BMPR-IB that encode 175 amino acids (aa) for
trBMPR-IA, 146 aa for trBMPR-IB plus 9 aa for influenza virus hemag-
glutinin (HA) epitope at the COOH terminus, were constructed with four
primers, as described below. The 5
 
9 
 
primers for trBMPR-IA and trBMPR-IB
were 5
 
9
 
-ACGTGCGAATTG-GACAATGA-3
 
9
 
 and 5
 
9
 
-TGGCGCTGA-
GCTATGACAAG-3
 
9
 
. The 3
 
9 
 
primers for trBMPR-IA and trBMPR-IB
were 5
 
9
 
-CTAAGCGTAGTCTGGGACGTCGTATGGGTAACAGAA-
GCAGCTGGAGAA-3
 
9
 
 and 5
 
9
 
-CTAAGCGTAGTCTGGGACGTCGTA-
TGGGTAACAGAATAAAATAAT-3
 
9
 
, which encoded for the comple-
mentary sequences of FSSCFC (aa 170–175) for trBMPR-IA or IILFC (aa
142–146) for trBMPR-IB, and YPYDVPDYA for HA peptide and stop
codon on each receptor. The amplified trBMPR-IA and trBMPR-IB PCR
products were cloned into PCRII vector using TA cloning kit (Invitrogen,
San Diego, CA). The trBMPR-IA and trBMPR-IB cDNAs in pCRII vec-
tor were digested with HindIII/XhoI, gel purified, and then subcloned into
pcDNA3 vector (Invitrogen). The plasmids were sequenced to verify ac-
curacy of the PCR amplification reaction. CaBMPR-IA (ALK3, Q233D),
caBMPR-IB (ALK6, Q203D) and wild-type BMPR-IB (ALK-6) expres-
sion plasmids were kindly provided by J. Wrana (The Hospital for Sick
Children, Toronto, Canada). These cDNA constructs were tagged with
HA epitope at their COOH terminus.
 
Transfection of 2T3 Cells
 
TrBMPR-IA, trBMPR-IB, caBMPR-IA, and caBMPR-IB expression
plasmids were stably transfected into 2T3 cells using lipofection method
(Strauss, 1996). 48 h after transfection, the cells were replated on 150- 
 
3
 
25-mm culture dishes at density of 10
 
5
 
 cells per dish. 
 
a
 
MEM containing
400 
 
m
 
g/ml G418 (GIBCO BRL, Gaithersburg. MD) was added. Colonies
grew after 2 wk and were cloned using cloning cylinders. In the rescue ex-
periment, wtBMPR-IB cDNA was transiently transfected into 2T3 clones
expressing trBMPR-IB. 2 d after transfection, BMP-2 was added to the
cultures. The cells were incubated for an additional 1 d and then assayed
for ALP activity using the Sigma ALP assay kit (Sigma Chemical Co., St.
Louis, MO). The transfection efficiency was estimated to be 80% by tar-
trate-resistant acid phosphatase (TRAP) in situ staining (Reddy et al.,
1993). 
 
Western Analysis
 
The 2T3 cells transfected with empty vector, trBMPR-IA, trBMPR-IB,
caBMPR-IA, caBMPR-IB, and wtBMPR-IB were lysed in lysis buffer (20
mM Hepes, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1.5 mM
MgCl
 
2
 
, and 1 mM EDTA) containing protease inhibitors and run on SDS-
PAGE gels (Mini-PROTEIN II Ready gels; Bio-Rad Laboratories, Inc.,
Hercules, CA). The proteins were transblotted on a nitrocellulose mem-
brane (Schleicher & Schuell) in transblotting buffer (20 mM Tris, 150 mM
glycine, 20% methanol, pH 8.0) at 4
 
8
 
C for 16 h. The membrane was
blocked with 5% BSA (Sigma Chemical Co.) in TBS for 2 h at room tem-
perature and then incubated with rabbit anti-HA polyclonal antibody (1:
1,000; Babco, Richmond, CA) in TBS for 2 h at room temperature. The
incubation with horseradish peroxidase-conjugated protein A (Kirke-
gaard & Perry Laboratories, Inc., Gaithersburg, MD) was performed at
room temperature for 2 h. The membrane was then washed with TBS con-
taining 0.1% Triton X-100 five times for 5 min and with TBS two times.
Immunostaining was detected using the enhanced chemiluminescence sys-
tem (Amersham Int., Buckinghamshire, UK).
 
Competitive Reverse Transcription-PCR Assay
 
In competitive reverse transcription (RT)-PCR assay, a DNA competitor
containing the same primer template sequences as the target competes for
primer binding and amplification (Feng et al., 1995). The competitor
DNA fragment was generated by PCR using BMPR-IA cDNA as tem-
plate. The upper and lower priming sites for detecting truncated and en-
dogenous type IA and IB BMP receptors were added to this competitor
by PCR. The upper primer for detecting truncated and endogenous type
IA receptors was 5
 
9
 
-TTACTGGGAGCCTGTCTG-3
 
9
 
 and the upper
primer for detecting truncated and endogenous type IB receptors was
5
 
9
 
-GCAACTCGGCCATAAGTG-3
 
9
 
. The lower primer for detecting
truncated type IA and IB BMP receptors was 5
 
9
 
-CGTCGTATGGGT-
AACAG-3
 
9
 
. The lower primers for detecting endogenous type IA and IB
receptors were 5
 
9
 
-GCCGAACCATCTGAATCT-3
 
9
 
 and 5
 
9
 
-AGCGGC-
CTTTTCCAATCT-3
 
9
 
. These primers have equal efficiency to amplify
truncated and endogenous receptor transcripts.
First strand cDNA was synthesized from 10 
 
m
 
g of total RNA with an
18-nucleotide oligo dT primer using Superscript reverse transcriptase
(GIBCO BRL) in a total volume of 50 
 
m
 
l. The cDNA was then used as a
template for PCR competition assay. For competitive PCR, 1 
 
m
 
Ci of [
 
a
 
-
 
32
 
P]-dCTP was added to each PCR reaction. 1 
 
m
 
l of RT cDNA, 1 
 
m
 
l of up-
per and lower primers (10 mM) each, and 1 
 
m
 
l of competitor (0.001, 0.01,
0.1, 1, 10, and 100 fmol) were then added to the PCR tubes with 45 
 
m
 
l of
PCR SuperMix (GIBCO BRL). After PCR amplification, a 10-
 
m
 
l sample
of PCR products from each reaction was run on agarose gels, stained with
ethidium bromide (50 
 
m
 
g/ml), photographed, dried, and then scanned us-
ing an AMBIS image acquisition and analysis system (AMBIS). The loga-
rithm of the ratio of truncated or endogenous BMP receptors to competi-
tor PCR products was plotted as a function of the logarithm of the known
amount of competitor added to the PCR reaction after size correction.
The molar concentration of truncated and endogenous BMP receptors
was calculated from the linear regression curves based on the known
amount of competitor added.
 
Mineralized Bone Matrix Formation Assay
 
Bone cell differentiation was monitored using a mineralized matrix forma-
tion assay as described by Bharagava et al. (1986). Von Kossa stain of
mineralized bone matrix was performed as follows. The cell cultures were
washed with PBS twice, fixed in phosphate-buffered formalin for 10 min
and then washed with water, and serially dehydrated in 70, 95, and 100%
ethanol, twice each, and then air dried. The plates were rehydrated from
100 to 95 to 80% ethanol/water before staining. The water was removed, a
2% silver nitrate solution was added, and then the plates were exposed to
sunlight for 20 min after which the plates were rinsed with water. 5% so-
dium thiosulfate was added for 3 min and the plates were then rinsed with
water. The modified van Gieson stain was then used as a counterstain af-
ter the von Kossa stain. The unmineralized collagen matrix can be recog-
nized by the yellow-red van Gieson stain. The acid fuchsin solution (5
parts of 1% acid fuchsin, 95 parts of picric acid, and 0.25 part of 12 M HCl)
was added for 5 min. The plates were washed with water and then with 2
 
3
 
95% ethanol, 2
 
3 
 
100% ethanol and then dried for image analysis.
The area of von Kossa-stained matrix was quantified by automated im-
age analysis using a video analysis program (Jandel Scientific, San Rafael,
CA) linked to a video screen camera (CCD/RGB; Sony Corp., Park
Ridge, NJ) and microscope (model BH2; Olympus Corp., Precision In-
struments Division, Lake Success, NY) equipped with metallurgical lenses.
Transmission electron microscopy was used to analyze the cell and ma-
trix structures. The cells were washed with PBS twice and fixed in 10 mM
of Na cacodylate buffer, pH 7.2, containing 2% glutaraldehyde overnight
at 4
 
8
 
C. The cells were then postfixed with 1% osmium tetroxide in 0.1 M
Na cacodylate buffer for 1 h at room temperature. The specimens were
dehydrated in an ethanol series, embedded in Polybed 812 resin (Poly-
science, Warrington, PA), polymerized for 72 h at 60
 
8
 
C, sectioned with a
Sorvall MT 5000 ultramicrotome (Sorvall, Inc., Norwalk, CT), and then
viewed in a JEOL 1200 EX transmission electron microscope (JEOL
USA, Inc., Peabody, MA).
 
Results
 
BMP-2 Induces 2T3 Cells to Differentiate into Mature 
Osteoblasts and Adipocytes
 
Previously, we characterized the osteoblast differentiation
properties of 2T3 cells (Ghosh-Choudhury et al., 1996).
BMP-2 induced 2T3 cells to differentiate into mature os-
teoblasts, indicating that 2T3 cells are precursors for the
osteoblast lineage. However, since other cells with this po-
tential also have the capability of differentiating along the
adipocyte lineage, we cultured 2T3 cells in an adipocyte-
promoting medium containing a PPAR
 
g
 
 ligand, indo-
methacin (Lehmann et al., 1997). We found that 2T3 cells 
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have a weak potential to differentiate into adipocytes if
cultured in this adipocyte-promoting medium and BMP-
2–enhanced adipocyte formation. This observation dem-
onstrates that 2T3 cells can also differentiate to a limited
extent into mature adipocytes if placed in the appropriate
environment (refer to Materials and Methods).
 
Expression of BMP Receptors in 2T3 Cells 
 
We examined expression of type IA, IB, and type II BMP
receptors in 2T3 cells. Expression of all three BMP recep-
tors was detected in 2T3 cells by Northern analysis. Two
transcripts for BMPR-IA, a single transcript for BMPR-
IB, and four transcripts for BMPR-II were detected using
DNA probes encoding the extracellular domain of the re-
ceptors. Expression levels of BMPR-IA were higher than
those of BMPR-IB in 2T3 cells as assayed with probes of
the same specific activity on duplicate RNA samples (Fig.
1). Addition of BMP-2 into 2T3 cell cultures decreased ex-
pression of BMPR-IA during osteoblast differentiation
but has no significant effects on BMPR-IB expression
(Fig. 1 
 
A
 
). Expression of the larger 11- and 12-kb BMPR-II
transcripts decreased with time (Fig. 1 
 
B
 
). Type II activin
receptor expression was also detected in 2T3 cells by
RT-PCR (data not shown).
 
Expression of Truncated BMP Receptors in 2T3 Cells
 
To test the function of type IA and IB BMP receptors in
2T3 cells, trBMPR-IA and trBMPR-IB cDNAs in the ex-
pression vector were independently and stably transfected
in 2T3 cells. The DNA sequence encoding HA peptide
was placed on the 3
 
9
 
 end of the receptor cDNA just after
the transmembrane domain. As a consequence, the kinase
domain of the receptor was deleted. The protein expres-
sion of truncated type IA and IB BMP receptors in three
independent clones for each mutant was detected by
Western analysis using anti-HA peptide antibody (Fig. 2
 
A
 
). Expression levels of truncated and endogenous type
IA and IB BMP receptor mRNAs were quantitated by
competitive RT-PCR (Fig. 2 
 
B
 
). The primers for detecting
mRNAs of truncated and endogenous BMPR-IA or
BMPR-IB did not amplify their counterparts. The mRNA
levels of truncated type IA and IB BMP receptors in three
different clones were over 10-fold higher than those of en-
dogenous type IA and IB BMP receptors. 
 
Effects of Truncated BMPR-IB on Bone
Matrix Formation   
 
During long-term cultures, 2T3 cells undergo a process of
proliferation followed by a low level of differentiation as
measured by mineralized bone matrix formation. The cells
are highly dependent on exogenous BMP-2 addition for
extensive differentiation and formation of mineralized
bone matrix. The mineralized bone matrix has the charac-
teristics of normal woven bone and is similar to the miner-
alized matrix produced by primary cultures of fetal rat cal-
varial (FRC) osteoblasts as determined by von Kossa
staining, electron microscopy analysis (Ghosh-Choudhury
et al., 1996) and Fourier transform infrared spectroscopy
(FTIR) analysis (our unpublished data).
Overexpression of trBMPR-IB in 2T3 cells completely
blocked BMP-2–induced mineralized bone matrix forma-
tion at all concentrations of BMP-2 (20–100 ng/ml) that in-
duced bone matrix formation in control 2T3 clones (Fig. 3,
 
A
 
 and 
 
B
 
). Time-course studies confirmed these results.
The 2T3 clones overexpressing trBMPR-IB formed multi-
layers but failed to form mineralized bone matrix during
the entire culture period (data not shown). In parallel ex-
periments, overexpression of the trBMPR-IA did not
block BMP-2–induced mineralized bone matrix formation
in 2T3 cells. Instead, it enhanced bone matrix formation in
Figure 1. Type IA, IB, and type II BMP receptor mRNA expres-
sion in 2T3 cells. 2T3 cells were cultured under conditions in
which mineralized bone matrix forms. Day 0 is defined as the day
the cells reach confluence and the medium is changed to aMEM
supplemented with 5% FCS, 100 mg/ml ascorbic acid, and 5 mM
b-glycerol phosphate with or without 40 ng/ml of BMP-2. (A)
Two transcripts (3.6 and 6.0 kb) of BMPR-IA, one transcript (6.2
kb) of BMPR-IB, and (B) four transcripts (5.0, 6.5, 11, and 12 kb)
of BMPR-II were detected in 2T3 cells.
Figure 2. Expression of truncated type IA and IB and constitu-
tively active type IA and IB BMP receptors in 2T3 cells. (A) Ex-
pression of trBMPR-IA (trIA) and trBMPR-IB (trIB) protein
(z30 kD) in 2T3 cells was detected by Western analysis using anti-
HA antibody. (B) Quantitation of expression levels of the trun-
cated and endogenous BMPR-IA (trIA and IA) and BMPR-IB
(trIB and IB) transcripts in 2T3 clones expressing trBMPR-IA
and trBMPR-IB. The generation of a competitor and RT-PCR
conditions were described in Materials and Methods. Increasing
concentrations of DNA competitor (Com) at concentrations of
0.001, 0.01, 0.1, 1, 10, and 100 fmol (left to right) were added to
each PCR reaction. The intensity of PCR products was quanti-
tated by an AMBIS image acquisition system. (C) Expression of
caBMPR-IA (caIA) and caBMPR-IB (caIB) protein (z55 kD) in
2T3 cells was detected by Western analysis using anti-HA anti-
body. 
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the absence of BMP-2 (Fig. 3, A and B). These observa-
tions suggest that BMPR-IB is primarily responsible for
BMP-2–induced osteoblast differentiation. The growth
rates of trBMPR-IB–expressing 2T3 clones were similar to
those of control 2T3 clones (data not shown), suggesting
that impairment of mineralized bone matrix formation is
not due to defects in cell growth or multilayering.
To determine if other BMP family members stimulate os-
teoblast differentiation through the same BMP receptor, we
examined the effect of BMP-7 (OP-1) on mineralized bone
matrix formation in control and trBMPR-IB–expressing
2T3 clones. BMP-7 induced mineralized bone matrix forma-
tion in a dose-dependent manner (50–200 ng/ml) in control
2T3 clones. Overexpression of trBMPR-IB completely
blocked BMP-7–induced mineralized bone matrix forma-
tion in these trBMPR-IB clones (Fig. 3 C). Overexpression
of trBMPR-IA in 2T3 cells did not block BMP-7–induced
mineralized bone matrix formation (Fig. 3 C). These obser-
vations suggest that BMP-7 and BMP-2 act through the
same BMP receptors to stimulate osteoblast differentiation.
To determine if other growth and differentiation factors
that mediate osteoblast differentiation were affected by
overexpression of trBMPR-IB, we examined the effect of
retinoic acid on ALP activity in control and trBMPR-
IB–expressing 2T3 clones. Retinoic acid stimulated ALP
activity in both cells at similar potency (data not shown),
suggesting that some differentiation functions of these cells
remains intact although BMPR-IB signaling is blocked.
Analysis of the Mineralized Bone Matrix Structure   
The mineralized bone matrix structure was analyzed by
the transmission electron microscopy. Similar to the pri-
mary FRC cell cultures, low levels of the mineralized ma-
trix were associated with unmineralized collagen fibrils be-
tween the cell layers in control 2T3 clones (Fig. 4, A and
C). Addition of BMP-2 to control 2T3 clones resulted in
massive increases in mature mineralized matrix in which
the collagen fibers were integrated into the mineral struc-
ture (Fig. 4, A and C). In cultures of 2T3 clones overex-
pressing trBMPR-IB, multiple cell layers were formed but
no mineralized matrix was found between the cell layers
even in the presence of BMP-2 (Fig. 4, B and C). There
was a large decrease in the collagen fibers formed between
the cell layers. The number of cells and of cell layers was
similar between control and trBMPR-IB–expressing 2T3
clones but the thickness of the culture of trBMPR-IB
clones was highly reduced due to the lack of extensive col-
lagen fibril containing matrix (Fig. 4, A and B). These
results indicate that the mineralization observed by von
Kossa staining is matrix-associated mineralization and that
overexpression of trBMPR-IB inhibits osteoblast terminal
differentiation in 2T3 cells.
Effects of Truncated BMPR-IB on
Osf2/Cbfa1 Expression
Osf2/Cbfa1 is an osteoblast-specific transcription factor.
Figure 3. Von Kossa stain of 2T3 clones containing the empty vector,
trBMPR-IA, trBMPR-IB and caBMPR-IB. (A) Effects of overexpression
of trBMPR-IA (trIA) and trBMPR-IB (trIB) on BMP-2–induced mineral-
ized bone matrix formation. The cells were cultured for 12 d in the presence
or absence of 100 ng/ml of BMP-2. After incubation, the cells were fixed
with 10% formalin and stained by von Kossa method. (B) The mineralized
bone matrix formation of 2T3 cells containing the empty vector (Vect); trIA and trIB were quantitated by computer image analyzer. The
data represent the mean 6 SE for three samples. (C) Effects of overexpression of trBMPR-IA (trIA) and trBMPR-IB (trIB) on BMP-7–
induced mineralized bone matrix formation. The cells were cultured for 12 d in the presence or absence of 200 ng/ml of BMP-7. (D) Ef-
fects of overexpression of caBMPR-IB (caIB) on mineralized bone matrix formation. The cells were cultured for 12 d and stained by
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Osf2/Cbfa1 mRNA was expressed in 2T3 cells and BMP-2
enhanced Osf2/Cbfa1 mRNA expression (Fig. 5 A). In
trBMPR-IB–expressing 2T3 clones, Osf2/Cbfa1 mRNA
expression was significantly decreased (Fig. 5 A) but in
trBMPR-IA–expressing 2T3 clones, Osf2/Cbfa1 mRNA ex-
pression and BMP-2 induction remain intact (data not
shown). These results suggest that BMP-2 stimulates Osf2/
Cbfa1 expression through the BMPR-IB and further demon-
strates the essential roles of the BMPR-IB in osteoblast dif-
ferentiation.
Effects of Truncated BMPR-IB on ALP and
OC Expression
Expression of several osteoblast differentiation-related
genes was examined in this study including ALP and OC.
Like FRC osteoblasts, ALP mRNA was expressed in the
early phase of differentiation and OC mRNA was ex-
pressed at initiation of the mineralization phase of differen-
tiation in 2T3 cells. BMP-2 enhanced ALP and OC mRNA
expression in control 2T3 clones. In trBMPR-IB–expres-
sing 2T3 clones, ALP and OC mRNAs were significantly
reduced in the absence or presence of BMP-2 (Fig. 5 B).
Overexpression of trBMPR-IB also inhibited ALP activity
and blocked BMP-2 induction of ALP in 2T3 cells (Fig. 6
B). These results are consistent with the studies reported
above showing that trBMPR-IB inhibited mineralized
bone matrix formation.
Rescue of the Phenotype of Truncated 
BMPR-IB Clones 
To further test the specificity of the effects of trBMPR-IB,
we transfected wtBMPR-IB into 2T3 clones containing
trBMPR-IB. Expression of wtBMPR-IB was detected by
Western analysis using anti-HA antibody (Fig. 6 A). The
wild-type and truncated BMPR-IB can be readily distin-
guished by size. The expression levels of wtBMPR-IB were
higher than those of trBMPR-IB (Fig. 6 A). Expression of
wtBMPR-IB in 2T3 clones containing trBMPR-IB rescued
suppressed ALP activity and more importantly, the
BMP-2 responsiveness (Fig. 6 B). These results suggest
that trBMPR-IB in 2T3 clones specifically blocks BMPR-IB
signaling.
Effects of Constitutively Active BMPR-IB on Bone 
Matrix Formation
To confirm the role of BMPR-IB in osteoblast differentia-
tion, we stably transfected caBMPR-IB (ALK6, Q203D)
in 2T3 cells. This caBMPR-IB has been shown to increase
Smad1 phosphorylation without a BMP ligand in transient
transfection assays (Hoodless et al., 1996). CaBMPR-IB
expression in three independent clones was detected by
Western analysis using anti-HA antibody (refer to Fig. 2
C). Expression of caBMPR-IB in these clones induced
mineralized bone matrix formation without addition of
BMP-2 (refer to Fig. 3 D). These results support the con-
cept that BMPR-IB signaling is required for osteoblast dif-
ferentiation.
Respecification of 2T3 Cells by Inhibition of BMPR-IB
Parent 2T3 cells, when cultured in the osteoblast differen-
tiation medium, differentiate into mature osteoblasts pro-
ducing an extensive mineralized bone matrix in the pres-
ence of BMP-2. Under these conditions, no adipocytes
were observed either in the absence or presence of BMP-2.
When control 2T3 clones were cultured in an adipocyte-
promoting medium containing 60 mM of indomethacin, a
PPARg ligand, a few mature adipocytes were observed by
Oil red O staining. A measurable increase in adipocyte
number was found in control 2T3 clones when 100 ng/ml
of BMP-2 was added to the culture media (Fig. 7, A and
B). However, when trBMPR-IB–expressing 2T3 clones
were cultured in this same adipocyte-supporting media, a
12-fold increase in the number of mature adipocytes was
observed and BMP-2 (100 ng/ml) further enhanced ma-
ture adipocyte formation (Fig. 7, A and B). Microscopic
examination of the cells demonstrated that trBMPR-IB–
expressing 2T3 clones had dramatic changes in morphol-
ogy from day 3 onward. The trBMPR-IB expressing clones
Figure 4. Transmission electron microscopic
analysis of the mineralized bone matrix structure
of 2T3 cells. (A and B) Empty vector control
(Vect) and trBMPR-IB (trIB)–expressing 2T3
clones were cultured for 12 d in the presence or
absence of 100 ng/ml of BMP-2 and fixed with
Na cacodylate and glutaraldehyde buffer for
electron microscopy analysis. (C) High magnifi-
cation of collagen fibers and mineralized bone
matrix of 2T3 cells containing the empty vector
(Vect) and trBMPR-IB (trIB). Arrows, unminer-
alized collagen fibers; arrowheads, mature min-
eralized matrix. Bars: (A and B) 2 mm; (C) 1 mm.Chen et al. BMP Receptors in Osteoblast and Adipocyte Differentiation 301
changed from a typical spindle-shaped osteoblast structure
to polygonal cells with perinuclear accumulations of fat
droplets in the cytoplasm. Highly differentiated adipocytes
with large lipid vacuoles were identified by Oil red O
staining at day 8 (Fig. 7, A and B). No adipocyte formation
was observed in 2T3 clones containing caBMPR-IB with
or without BMP-2 in this adipogenic media (data not shown).
These results demonstrate that BMPR-IB may be essen-
tial not only for osteoblast differentiation but also for the
commitment and specification to the osteoblast lineage. 
Effects of BMPR-IA on Adipocyte Formation
Since addition of BMP-2 further enhanced adipocyte for-
mation in trBMPR-IB–expressing clones, we then exam-
ined if BMPR-IA is involved in this BMP-2–stimulated
adipocyte formation. We transfected trBMPR-IA and
caBMPR-IA cDNAs into 2T3 cells. Expression of these
mutant receptors was detected by Western analysis using
anti-HA antibody (refer to Fig. 2, A and C). 2T3 clones
containing trBMPR-IA show no tendency to form adipo-
cytes in the same adipocyte-promoting medium, even in
the presence of BMP-2. The cells have a typical fibroblas-
tic morphology (Fig. 7 C). Expression of caBMPR-IA in
2T3 cells induced adipocyte formation even without addi-
tion of BMP-2 (Fig. 7 C). These results suggest that
BMPR-IA plays important roles in adipocyte differentia-
tion.
Expression of Adipocyte Differentiation-related Genes
Expression of the mature adipocyte marker genes, adipsin
and PPARg, was examined by Northern analysis. The cells
were cultured in the adipocyte-promoting media. Adipsin
mRNA expression was only detected in 2T3 clones overex-
pressing trBMPR-IB at day 8. It was not detected in control
or trBMPR-IA clones, either in the absence or presence of
BMP-2 (Fig. 8 A). PPARg mRNA expression was detected
during the entire culture period in 2T3 clones containing
empty vector, trBMPR-IA, and trBMPR-IB. However,
in trBMPR-IB–expressing 2T3 clones, PPARg mRNA ex-
pression was about threefold higher than control 2T3
clones. Addition of BMP-2 further enhanced both adipsin
and PPARg mRNA expression in trBMPR-IB–expressing
clones (Fig. 8, A and B). In trBMPR-IA–expressing 2T3
clones, PPARg mRNA expression was lower compared
with control 2T3 clones and BMP-2 further suppressed
PPARg mRNA expression (Fig. 8, A and B). These results
support the observation at the molecular level that the
specification of 2T3 cells has been reprogrammed by selec-
tively blocking a subtype of BMP receptor family.
Discussion
In this study, we examined the roles of type IA and IB
BMP receptors in the commitment and differentiation of
clonal 2T3 cells. The osteoblast differentiation properties
of 2T3 cells have been characterized extensively in our
laboratory. BMP-2, BMP-4, and BMP-6, and type IA, IB,
and type II BMP receptors and type II activin receptor are
expressed in 2T3 cells. BMP-2 stimulates BMP-2 and
BMP-4 mRNA expression and suppresses BMPR-IA
mRNA expression during osteoblast differentiation. BMP-2
and BMP-7 stimulate ALP activity, osteoblast differentia-
tion-related gene expression, and mineralized bone matrix
formation in 2T3 cells. 2T3 cells have retained the osteo-
blast differentiation properties up to passage 50. In the
present study, we used passage 15 of 2T3 cells for the trans-
fection and differentiation studies. To rule out the possi-
bility of clonal variation, we characterized three indepen-
dent clones for each stable transfection of mutant BMP
receptors. The structure and mineral composition of the
mineralized bone matrix produced by 2T3 cells have been
Figure 5. Osf2/Cbfa1, alkaline phosphatase (ALP) and osteocal-
cin (OC) mRNA expression in 2T3 cells. 2T3 cells containing the
empty vector (Vect) or trBMPR-IB (trIB) were cultured for 8 d in
aMEM containing 5% FCS, 100 mg/ml ascorbic acid, and 5 mM
b-glycerol phosphate with or without 40 ng/ml of BMP-2. (A and
B) The Osf2/Cbfa1 (6.0 kb), ALP (3.0 kb), and OC (0.5 kb)
mRNA expression was detected by Northern analysis.
Figure 6. Effects of BMP-2 on ALP activity in 2T3 cells. 2T3
clones expressing trBMPR-IB was transiently transfected with
wtBMPR-IB. (A) Expression of wtBMPR-IB (wtIB) and trBMPR-
IB (trIB) in 2T3 clones expressing trBMPR-IB was detected by
Western analysis. (B) ALP activity and BMP-2 (100 ng/ml) re-
sponse was assayed in control, trBMPR-IB and wtBMPR-IB/
trBMPR-IB clones. The unit of ALP activity is nanomoles of
p-nitrophenol formed per microgram of protein per minute. Data
are the mean 6 SE for three samples.The Journal of Cell Biology, Volume 142, 1998 302
characterized by electron microscopy analysis and FTIR.
They are similar to the normal woven bone and the miner-
alized bone matrix produced by primary cultures of FRC
osteoblasts. These features make 2T3 cells an ideal model
for osteoblast differentiation and mineralization studies
since many osteosarcoma cell lines have incomplete phe-
notypes and lack the mineralization capacity for terminal
differentiation evaluation.
Osteoblast Differentiation in 2T3 Cells
Parent 2T3 cells form an extensive mineralized bone ma-
trix in the presence of BMP-2. 2T3 clones containing trun-
cated BMPR-IB fail to form mineralized bone matrix, even
with addition of high concentrations of BMP-2. Bone cell
differentiation is completely blocked but growth and multi-
layering is unaffected. The lack of an extensive collagen-
fibril matrix was found in truncated BMPR-IB–expressing
clones. Expression of the osteoblast specific transcription
factor, Osf2/Cbfa1, and osteoblast differentiation-related
genes, ALP and OC, was significantly inhibited. The basal
ALP activity and BMP-2 induction were also inhibited.
These observations demonstrate that BMPR-IB is re-
quired for osteoblast differentiation. Expression of a con-
stitutively active BMPR-IB induced osteoblast differentia-
tion without a ligand, further supporting this conclusion.
Adipocyte Differentiation in 2T3 Cells 
Parent 2T3 cells can be induced to differentiate into a
small number of mature adipocytes in the adipocyte-pro-
moting medium and BMP-2 enhances adipocyte formation
in these cells. By expressing truncated BMPR-IA in 2T3
cells, the capacity of 2T3 cells to form mature adipocytes is
blocked, even in the presence of BMP-2. The expression
profile of adipocyte marker genes, adipsin and PPARg,
correlated with these phenotypic changes. Basal levels of
PPARg expression in 2T3 clones containing truncated
Figure 7. Adipocyte formation in 2T3 cells containing different
mutant BMP receptors. (A) 2T3 cells containing the empty vector
(Vect) and trBMPR-IB (trIB) were cultured for 8 d in aMEM
containing 5% rabbit serum, 0.5 mM IBMX, and 60 mM in-
domethacin in the presence or absence of 100 ng/ml of BMP-2.
After incubation, the cells were fixed with 10% formalin and
stained with 0.2% Oil red O solution. (B) Oil red O–positive
staining adipocytes in control and trBMPR-IB–expressing clones
were quantitated using a phase-contrast microscope. The data
represents the mean 6 SE for three samples. (C) Adipocyte for-
mation in 2T3 cells expressing trBMPR-IA (trIA) and caBMPR-
IA (caIA) in the presence or absence of 100 ng/ml of BMP-2. After
8 d of incubation, the cells were stained by the Oil red O staining
method.Chen et al. BMP Receptors in Osteoblast and Adipocyte Differentiation 303
BMPR-IA are lower compared with control 2T3 clones
and suppressed by BMP-2 as in control 2T3 clones. 2T3
clones overexpressing constitutively active BMPR-IA
form mature adipocytes without addition of BMP-2. The
results demonstrate that adipocyte differentiation stimu-
lated by BMP-2 is mediated through BMPR-IA signaling.
The results also suggest that BMP-2 may stimulate adipo-
cyte differentiation partly by enhancing expression of
PPARg, a key molecule for adipocyte differentiation. It
has been reported that just overexpression of PPARg
cDNA in NIH-3T3 fibroblasts and activation of PPARg
receptor by PPARg ligands, prostaglandin J2 metabolites,
in pluripotent precursor C3H10T1/2 cells can induce these
cell lines into mature adipocytes (Kliewer et al., 1995;
Brun et al., 1996). This is further supported by the fact that
2T3 clones containing truncated BMPR-IB spontaneously
form adipocytes and BMP-2 further enhances adipocyte
differentiation process. Adipsin mRNA is expressed in
2T3 clones containing truncated BMPR-IB and not in
empty vector or parent 2T3 clones. Adipsin mRNA is also
increased with BMP-2 addition in 2T3 clones containing
truncated BMPR-IB.
Commitment of Precursor Cells
Studies of stromal cell transplantation in vivo (Frieden-
stein et al., 1987) and analysis of different mouse or rat
clonal cell populations in vitro (Bennett et al., 1991; Beres-
ford et al., 1992) provide evidence that multipotential mes-
enchymal cells can differentiate into different cell types in-
cluding osteoblasts, chondroblasts, and adipocytes. These
mesenchymal cells have the capacity to undergo the com-
mitment process to give rise to progeny with more limited
or monopotential differentiation capacity. The mechanism
of the commitment and the specification of osteoblasts and
adipocytes is not fully understood. BMPs appear to play
regulatory roles during osteoblast and adipocyte differenti-
ation processes (Aubin et al., 1995). Type IA BMP receptor
expression was detected in preadipocyte BMS2 cells (Gim-
ble et al., 1995), osteoblast MC3T3-E1 cells (Heffel et al.,
1997), and myoblast C2C12 cells (Namiki et al., 1997). In
the present study, we found that selectively blocking
BMPR-IB in 2T3 cells respecified cells to differentiate into
adipocytes instead of osteoblasts. These results suggest that
expression of BMPR-IB in mesenchymal precursor cells is
required for commitment of the osteoblast lineage. Overex-
pression of truncated BMPR-IA in 2T3 cells blocked adipo-
cyte differentiation and promoted osteoblast differentia-
tion. These results suggest that high levels of BMPR-IA
signaling are involved in adipocyte differentiation. The re-
sults of overexpression of constitutively active type IA or IB
BMP receptors in 2T3 cells further support these findings. 
The Specificity of Phenotypes of Mutant
Receptor Clones
The kinase domains and kinase activities of type I BMP
receptors are dispensable for receptor complex formation
but are required to transmit a signal to the nucleus (Mas-
sagué, 1996). The truncated type I and type II BMP recep-
tors without kinase domain or with mutations in the kinase
domain have been shown to block BMP signaling effi-
ciently in vivo and in vitro (Graff et al., 1994; Maeno et al.,
1994; Suzuki et al., 1994). Our observations indicate that
truncated type IB and IA BMP receptors act as a domi-
nant-negative mutants to block osteoblast or adipocyte
differentiation induced by BMPs.
The specificity of type IA and IB BMP receptor signal-
ing in osteoblast and adipocyte differentiation has been
supported by several lines of evidence in this study. First,
expression of truncated BMPR-IB in 2T3 cells completely
blocked osteoblast differentiation and mineralized bone
matrix formation. This was not seen in 2T3 clones overex-
pressing truncated BMPR-IA. Similarly, expression of
truncated BMPR-IA in 2T3 cells blocked adipocyte differen-
tiation and expression of truncated BMPR-IB induced adipo-
cyte differentiation. Second, constitutively active BMPR-IB
and BMPR-IA induced mineralized bone matrix forma-
tion and adipocyte formation, respectively, without addi-
tion of BMP-2. These results support the findings that
truncated BMPR-IB or truncated BMPR-IA blocked oste-
oblast or adipocyte differentiation in 2T3 cells, respectively.
Finally, we have been able to rescue the ALP activity and
BMP-2 responsiveness by overexpression of wild-type
BMPR-IB in 2T3 clones containing truncated BMPR-IB. 
Signaling Pathways of BMPR-IA and BMPR-IB
One of the earliest downstream signals of BMP-2 action is
the activation and nuclear translocation of the mothers-
against-dpp (MAD) family members or Smad proteins
(Hoodless et al., 1996; Nishimura et al., 1998). When
Smad1 is translocated to the nucleus it can supply a tran-
scriptional activation domain and DNA-binding domain
which then, in turn, interact with other DNA-binding tran-
scription factors, resulting in activating or repressing specific
genes (Liu et al., 1996). One possibility is that BMPR-IA
and BMPR-IB can activate different signaling molecules or
different transcription factors after forming a complex with
different type II receptors. For example, activin is known to
signal cells through Smad2 protein. Smad2 can then interact
with a specific target cell wing-helix-loop-helix transcription
factor, FAST1 (Chen et al., 1996). Thus, BMP-2 may signal
through a BMP type II or activin type II receptor com-
plexed with a specific BMP type I receptor. These differ-
Figure 8. Adipocyte marker gene expression in 2T3 cells. 2T3
cells containing the empty vector (Vect), trBMPR-IA (trIA), and
trBMPR-IB (trIB) were cultured for 8 d in aMEM containing 5%
rabbit serum, 0.5 mM IBMX, and 60 mM of indomethacin with or
without 40 ng/ml of BMP-2. (A) Adipsin (1.0 kb) and PPARg
(1.9 kb) mRNA expression were detected by Northern analysis.
(B) The levels of PPARg mRNA expression was quantitated and
normalized to GAPDH levels.The Journal of Cell Biology, Volume 142, 1998 304
ent complexes can generate different signaling pathways
responsible for alternate paths of differentiation. More de-
tailed studies are required to address this issue.
Recent studies on activin receptor signaling also suggest
that different subtypes of activin receptors transduce alter-
nate biological signals. Truncated type IB activin receptor
blocked activin-induced transcriptional activity in both
Chinese hamster ovary and K562 human erythroleukemic
cells, whereas truncated type I (IA) activin receptor had no
effect in either cell line (Tsuchida et al., 1995). Our results
now demonstrate functional differences of the BMP recep-
tor subtypes in their capacity to induce multipotent cells to
differentiate along osteoblast or adipocyte lineages.
Downstream Target Genes of Type IA and IB BMP 
Receptor Signaling
Osf2/Cbfa1 is an osteoblast-specific transcription factor. A
total lack of bone and retention of the partially calcified
cartilagenous skeleton were found in Osf2/Cbfa1 knock-
out mice. Both membranous bone of the skull and endo-
chondral bone in the rest of the skeleton were absent in
Osf2/Cbfa1 knockout mice. Mutation of Osf2/Cbfa1 gene
is found in humans with cleidocranial dysplasia (Ducy et al.,
1997; Komori et al., 1997; Mundlos et al., 1997; Otto et al.,
1997). These findings indicate that Osf2/Cbfa1 plays essen-
tial roles in bone formation. Osf2/Cbfa1 is a downstream
molecule of BMP action since BMP-7 induced Osf2/Cbfa1
mRNA expression in C3H10T1/2 cells. In the present
study, we demonstrated that expression of Osf2/Cbfa1 was
enhanced by BMP-2 and blocked by truncated BMPR-IB
in 2T3 cells. These results suggest that BMP-2 stimulates
Osf2/Cbfa1 expression through BMPR-IB.
Similar to Osf2/Cbfa1 in osteoblast differentiation, PPARg
is a critical molecule for adipocyte differentiation. Expres-
sion of truncated BMPR-IA suppresses PPARg mRNA
expression and expression of truncated BMPR-IB enhances
PPARg mRNA expression, suggesting that PPARg may be
one of the important downstream target genes for BMPR-IA
signaling during adipocyte differentiation.
In summary, we have demonstrated that type IB and IA
BMP receptors play essential roles for commitment and
differentiation of osteoblasts and adipocytes. Commit-
ment of osteoblasts and adipocytes can be respecified by
selectively blocking or activating type IB or IA BMP re-
ceptor signalling. This finding suggests that the temporal
acquisition or loss of a subtype of BMP receptors in pre-
cursor cells may be a key step for commitment and differ-
entiation of osteoblasts and adipocytes.
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